Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Conditions: Multiple Myeloma Interventions: Drug: Elranatamab Sponsors: Pfizer Not yet recruiting

Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials